Results 181 to 190 of about 69,376 (247)

Optimizing Charpy Impact Strength of Material‐Extruded PLA Through Layer Height, Raster Angle, and Infill Geometry

open access: yesJournal of Applied Polymer Science, EarlyView.
Charpy impact performance of material‐extruded PLA is governed by the coupled effects of layer height, raster angle, and infill geometry. Full‐factorial testing identifies layer height as the dominant factor and reveals a strong layer‐height–raster‐angle interaction.
Yazan Mashaki   +4 more
wiley   +1 more source

A Novel Re-Entrant Honeycomb with Tunable Auxetic Response and Enhanced In-Plane Mechanical Performance. [PDF]

open access: yesMaterials (Basel)
Li C   +9 more
europepmc   +1 more source

Raman Response of Monolayer Graphene Upon Varying TCNE Adsorption

open access: yesAdvanced Physics Research, EarlyView.
Low TCNE loading induces p‐type doping in monolayer graphene without significantly disturbing local lattice symmetry, due to a structurally favorable molecular arrangement. At higher TCNE concentrations, the D‐band emergence indicates increasing symmetry breaking. TCNE thus enables concentration‐dependent tuning of graphene's electronic properties with
Simon Attenberger   +3 more
wiley   +1 more source

MicroCT reinvestigation of the only articulated fossil anostomid fish reveals synonymy of Arhinolemur Ameghino, 1898 and Megaleporinus Ramirez et al., 2017

open access: yesThe Anatomical Record, EarlyView.
Abstract Arhinolemur scalabrinii† Ameghino, 1898 was originally described as a strepsirrhine primate (Mammalia) but has been recognized as an anostomid fish since 2012. It remains the only extinct anostomid species known from complete cranial material.
Karen M. Panzeri   +8 more
wiley   +1 more source

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

open access: yesArthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia   +16 more
wiley   +1 more source

Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

open access: yesArthritis &Rheumatology, EarlyView.
Objective Rheumatoid arthritis (RA) often involves extra‐articular complications, including interstitial lung disease (ILD) and/or pulmonary nodules. Transcriptomic profiling of lung tissue provides the opportunity to directly assess cell‐specific gene expression and corresponding pathway activation in different types of rheumatoid lung disease ...
Tracy Tabib   +8 more
wiley   +1 more source

Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real‐world data from the ILD‐PRO Registry

open access: yesArthritis &Rheumatology, Accepted Article.
Objective We evaluated baseline characteristics, treatment patterns, and outcomes in patients with systemic autoimmune rheumatic disease‐associated progressive pulmonary fibrosis (SARD‐PPF) and evaluated whether outcomes differed by SARD subtype. Methods The ILD‐PRO Registry is a prospective multicenter US registry of patients with PPF.
Sonali J Bracken   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy